Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Array Biopharma Inc (ARRY)

15.56 2.42 (18.42%)

01-22 16:00

Open:

14.96

Pre. Close:

13.14

High:

16

Low:

14.26

Volume:

17,645,948

Market Cap:

3066M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

16.021 - 16.086

16.086 - 16.147

Low:

14.113 - 14.179

14.179 - 14.241

Close:

15.448 - 15.558

15.558 - 15.663

Technical analysis  (as of: 2018-01-22 4:24:07 PM)

Overall:

      

Stoxline posted a STRONG BUY today, upgraded from lower rating. This stock seems to be very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.

Target:

Six months: 18.69     One year: 21.83

Support:

Support1: 12.63    Support2: 10.54

Resistance:

Resistance1: 16.00    Resistance2: 18.69

Pivot:

13.46

Moving Averages:

MA(5): 13.55     MA(20): 13.18

MA(100): 11.54     MA(250): 10.05

MACD:

MACD(12,26): 0.62     Signal(12,26,9): 0.55

%K %D:

%K(14,3): 56.13     %D(3): 48.11

RSI:

RSI(14): 71.54

52-Week:

High: 16  Low: 6.73  Change(%): 40.6

Average Vol(K):

3-Month: 379304  10-Days 497150

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
ARRY has closed above the upper band by 26.4%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 37.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 22 Jan 2018 16:52:30 GMT
Why Array BioPharma Inc. Is Soaring

Mon, 22 Jan 2018 10:41:15 GMT
Array Biopharma (ARRY) Reports Updated Results for Phase 3 BEACON CRC Trial ...

Mon, 22 Jan 2018 14:30:09 GMT
Pre-Open Movers 01/22: (BIVV) (JUNO) (ARRY) Higher; (SANM) (TEVA) (TWTR) Lower ...

Thu, 28 Dec 2017 20:45:33 GMT
Lifshitz & Miller LLP Announces Investigation of Alteryx, Inc., Array ...

Fri, 19 Jan 2018 16:18:45 GMT
Buy or Sell? What Analysts Recommends: Array BioPharma Inc. (ARRY), Paratek ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

197.03

Shares Float (M)

193.96

% Held by Insiders

% Held by Institutions

97.30

Shares Short (K)

15174

Shares Short Prior Month (K)

21960

Stock Financials

EPS

-0.720

EPS Est. Current Year

-0.990

EPS Est. Next Year

-0.390

EPS Est. Next Quarter

-0.230

Forward EPS

-0.580

Book Value (p.s.)

11.420

PEG Ratio

-1.30

Profit Margin

Operating Margin

-240.35

Return on Assets (ttm)

-37.3

Return on Equity (ttm)

-146.6

Qtrly Rev. Growth

45.3

Gross Profit (p.s.)

0.343

Sales Per Share

EBITDA (p.s.)

-0.466

Qtrly Earnings Growth

Operating Cash Flow (M)

-42.79

Levered Free Cash Flow (M)

-22.49

atoplab.com

Valuation

P/E

-21.61

P/E Growth Ratio

0.18

P/BV

1.36

P/S

10949238784.00

P/CF

-71.65

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.